Biomedica Immunoassays provides internationally recognized, high quality ELISAs for clinical research in the field of bone and mineral disorders as well as renal and cardiovascular diseases. Biomedica serves international academic scientific institutions, CROs, and laboratories in the pharmaceutical industry. All assays are fully validated according to ICH-Q2 guidelines and include serum-based calibrators and controls for biologically reliable data. New in the ELISA portfolio is Bioactive Sclerostin, soluble Semaphorin 4D, and Periostin. Since 2017, Biomedica exclusively distributes TAmiRNA’s osteomiR™ miRNA biomarker assay which serves as a novel fracture-risk assessment tool.
Visit us at our Biomedica booth # 9 (